• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
PVP-K30-----pharma excipients(CAS No.9003-39-8)
Tobramycin
Povidone iodine 20% powder
Povidone iodine 10% powder
SULBACTAM SODIUM STERILE
Food Additives Bulk Sucralose Neotame Advantame Powder

Chinese mainland reports 108 new locally transmitted COVID-19 cases

chinadailyAugust 11, 2021

Tag: COVID-19 , daily report , NHC

The Chinese mainland on Monday reported 108 new locally transmitted COVID-19 cases, including 50 in Jiangsu Province, 37 in Henan, 15 in Hubei and six in Hunan, the National Health Commission said in its daily report on Aug 10.

Chinese mainland reports 108 new locally transmitted COVID-19 cases

Also reported were 35 new imported cases, including 11 in Yunnan, nine in Shanghai, eight in Guangdong, three each in Fujian and Sichuan, and one in Shaanxi.

One suspected case arriving from outside the mainland was newly reported in Fujian on Monday.

No deaths related to COVID-19 were newly reported, the commission added. 


Previous:U.S. Kids Are Eating More 'Ultraprocessed' Foods

Next:Veraxa Biotech and Indivumed to Jointly Develop Precision Oncology Antibody Drugs

Related News

InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 for Acute Myeloid Leukemia in China

PharmaSourcesSeptember 19, 2024

InnoCare Pharma announced today the approval of the Investigational New Drug (IND) to conduct the clinical trial of B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in combination with azacitidine for acute myeloid leukemia (AML) in China.

Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner

PharmaSourcesSeptember 18, 2024

Latest Data of InnoCare’s Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2024

PharmaSourcesSeptember 14, 2024

Chinese mainland reports 108 new locally transmitted COVID-19 cases | Pharmasources.com

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study

Biotech NewswireAugust 28, 2024

Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis.The results showed there is no evidence of excess cardiovascular risk.

You may like
More>>

Real Time Multiplex RT-PCR Kit (for COVID-19)

Real Time Multiplex RT-PCR Kit (for COVID-19)
SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)

SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)
CIPROFLOXACINHCL

CIPROFLOXACINHCL
BUPROPIONHCL

BUPROPIONHCL
PuriActives®ZnHC

PuriActives®ZnHC
DOPAMINHCL

DOPAMINHCL
Carbic anhCarbic anhydrideydride

Carbic anhCarbic anhydrideydride
LINCOMYCINHCL

LINCOMYCINHCL
PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM
LINCOMYCIN HCL

LINCOMYCIN HCL

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service